PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19157634-4	2009	In this study, we characterize the role of celecoxib in the cytotoxicity, ERK1/2 activation and Rad51 expression affected by gefitinib in NSCLC cells.	Celecoxib	43-52	mitogen-activated protein kinase 3	Homo sapiens	74-80	
19157634-8	2009	Furthermore, blocking ERK1/2 activation by U0126 (MKK1/2 inhibitor) and knocking down Rad51 expression by transfection with small interfering RNA of Rad51 can enhance the cytotoxicity of celecoxib.	Celecoxib	187-196	mitogen-activated protein kinase 3	Homo sapiens	22-28